Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Freeman

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Nature Immunology|November 6, 2001
Tob is a negative regulator of activation that is expressed in anergic and quiescent T cellsD Tzachanis, G J Freeman, N Hirano, et al.
The Journal of Clinical Investigation|April 4, 2001
B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4D A Mandelbrot, M A Oosterwegel, K Shimizu, et al.
The Journal of Clinical Investigation|May 1, 1989
Interleukin 6 gene expression in normal and neoplastic B cellsG J Freeman, A S Freedman, S N Rabinowe, et al.
Blood|December 31, 1997
In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferationD M Dorfman, J L Schultze, A Shahsafaei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cellsS Agrawal, J Marquet, G J Freeman, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995
Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicityJ L Schultze, A A Cardoso, G J Freeman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptorG J Freeman, A A Cardoso, V A Boussiotis, et al.
Blood|September 1, 1994
The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigenP Engel, J G Gribben, G J Freeman, et al.
Science (New York, N.Y.)|November 5, 1993
Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferationG J Freeman, J G Gribben, V A Boussiotis, et al.
Mucosal Immunology|November 15, 2012
TIM-4, expressed by medullary macrophages, regulates respiratory tolerance by mediating phagocytosis of antigen-specific T cellsL A Albacker, S Yu, D Bedoret, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Nature Immunology|November 6, 2001
Tob is a negative regulator of activation that is expressed in anergic and quiescent T cellsD Tzachanis, G J Freeman, N Hirano, et al.
The Journal of Clinical Investigation|April 4, 2001
B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4D A Mandelbrot, M A Oosterwegel, K Shimizu, et al.
The Journal of Clinical Investigation|May 1, 1989
Interleukin 6 gene expression in normal and neoplastic B cellsG J Freeman, A S Freedman, S N Rabinowe, et al.
Blood|December 31, 1997
In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferationD M Dorfman, J L Schultze, A Shahsafaei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cellsS Agrawal, J Marquet, G J Freeman, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995
Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicityJ L Schultze, A A Cardoso, G J Freeman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptorG J Freeman, A A Cardoso, V A Boussiotis, et al.
Blood|September 1, 1994
The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigenP Engel, J G Gribben, G J Freeman, et al.
Science (New York, N.Y.)|November 5, 1993
Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferationG J Freeman, J G Gribben, V A Boussiotis, et al.
Mucosal Immunology|November 15, 2012
TIM-4, expressed by medullary macrophages, regulates respiratory tolerance by mediating phagocytosis of antigen-specific T cellsL A Albacker, S Yu, D Bedoret, et al.
Pageof 12